Literature DB >> 19955006

Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopathological and survival analysis.

Fernanda Seixas1, Carlos Palmeira, Maria Anjos Pires, Maria José Bento, Carlos Lopes.   

Abstract

Feline mammary carcinomas (FMC) are highly infiltrative tumours which show a strong tendency for local recurrence and metastasis. Histological type assessment of these tumours is not sufficiently discriminatory in predicting prognosis and in this study the prognostic significance of the Elston and Ellis method of histological grading was evaluated. Ninety-two feline mammary carcinomas from 84 cats were graded and 64 queens were included in a follow-up study. Grade was significantly related to tumour size (P=0.006), clinical stage (P=0.005), lymphovascular invasion (P<0.0001), mitotic index (P<0.0001), Ki67 index (P=0.001), overall survival (P=0.0001) and disease-free survival (P<0.0001). Cox regression analysis identified grade as an independent prognostic factor. Multivariable analysis also showed regional lymph node metastasis and lymphovascular emboli as independent prognostic factors related to overall survival and to disease-free-survival, respectively. The study demonstrated that histological grading can be used as a prognostic factor to evaluate the biological behaviour of FMC. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19955006     DOI: 10.1016/j.tvjl.2009.10.030

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  14 in total

1.  Is melatonin of value in cancer treatment? Experience with a case of feline mammary carcinoma.

Authors:  Beverly Baxter
Journal:  Can Vet J       Date:  2017-07       Impact factor: 1.008

2.  St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study.

Authors:  M Soares; J Correia; M C Peleteiro; F Ferreira
Journal:  Tumour Biol       Date:  2015-10-20

3.  Classification and grading of canine malignant mammary tumors.

Authors:  Abbas Tavasoly; Hannaneh Golshahi; Annahita Rezaie; Mohammad Farhadi
Journal:  Vet Res Forum       Date:  2013       Impact factor: 1.054

4.  Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.

Authors:  Ana Catarina Figueira; Catarina Gomes; Joana Tavares de Oliveira; Hugo Vilhena; Júlio Carvalheira; Augusto J F de Matos; Patrícia Dias Pereira; Fátima Gärtner
Journal:  BMC Vet Res       Date:  2014-11-26       Impact factor: 2.741

5.  Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status.

Authors:  Maria Soares; Rita Ribeiro; Shabir Najmudin; Andreia Gameiro; Rita Rodrigues; Fátima Cardoso; Fernando Ferreira
Journal:  Oncotarget       Date:  2016-04-05

6.  Intermediate-grade mammary gland adenocarcinoma in an 18-year-old female black leopard (Panthera pardus) with acute pancreatic necrosis and chronic interstitial nephropathy.

Authors:  Misato Nakamura; Toshinori Yoshida; Ayumi Eguchi; Mari Inohana; Rei Nagahara; Ayako Shiraki; Nanao Ito; Makoto Shibutani
Journal:  J Vet Med Sci       Date:  2017-12-19       Impact factor: 1.267

7.  Gene expression association study in feline mammary carcinomas.

Authors:  Daniela Ferreira; Bárbara Martins; Maria Soares; Jorge Correia; Filomena Adega; Fernando Ferreira; Raquel Chaves
Journal:  PLoS One       Date:  2019-08-28       Impact factor: 3.240

Review 8.  Cat Mammary Tumors: Genetic Models for the Human Counterpart.

Authors:  Filomena Adega; Ana Borges; Raquel Chaves
Journal:  Vet Sci       Date:  2016-08-16

Review 9.  Cytogenomics of Feline Cancers: Advances and Opportunities.

Authors:  Rachael Thomas
Journal:  Vet Sci       Date:  2015-08-31

10.  Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 2: Feline Mammary Carcinomas.

Authors:  Florian Chocteau; Marie-Mélanie Boulay; Fanny Besnard; Germain Valeau; Delphine Loussouarn; Frédérique Nguyen
Journal:  Front Vet Sci       Date:  2019-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.